Terms: = Thyroid cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884
44 results:
1. Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
Yang F; Li X; Zhang Y; Ren Y; Zhang J; Xiao K
Medicine (Baltimore); 2024 Mar; 103(12):e37477. PubMed ID: 38518016
[TBL] [Abstract] [Full Text] [Related]
2. Combination therapy of tyrosine kinase inhibitor sorafenib with the hsp90 inhibitor onalespib as a novel treatment regimen for thyroid cancer.
Mortensen ACL; Berglund H; Hariri M; Papalanis E; Malmberg C; Spiegelberg D
Sci Rep; 2023 Oct; 13(1):16844. PubMed ID: 37803074
[TBL] [Abstract] [Full Text] [Related]
3. Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for cancer Treatment - Pharmacology and Mechanisms.
Xing Z; Su A; Mi L; Zhang Y; He T; Qiu Y; Wei T; Li Z; Zhu J; Wu W
Drug Des Devel Ther; 2023; 17():2909-2929. PubMed ID: 37753228
[TBL] [Abstract] [Full Text] [Related]
4. Isoquercitrin Induces Endoplasmic Reticulum Stress and Immunogenic Cell Death in Gastric cancer Cells.
Liu J; Ren L; Wang H; Li Z
Biochem Genet; 2023 Jun; 61(3):1128-1142. PubMed ID: 36480095
[TBL] [Abstract] [Full Text] [Related]
5. Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study.
Oliinyk D; Augustin T; Rauch J; Koehler VF; Belka C; Spitzweg C; Käsmann L
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3527-3547. PubMed ID: 35960373
[TBL] [Abstract] [Full Text] [Related]
6. Molecular Chaperones and thyroid cancer.
Paladino L; Vitale AM; Santonocito R; Pitruzzella A; Cipolla C; Graceffa G; Bucchieri F; Conway de Macario E; Macario AJL; Rappa F
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919591
[TBL] [Abstract] [Full Text] [Related]
7. HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma.
Huang J; Zhao X; Li X; Peng J; Yang W; Mi S
PLoS Biol; 2021 Apr; 19(4):e3001197. PubMed ID: 33905408
[TBL] [Abstract] [Full Text] [Related]
8. Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of thyroid Carcinoma Cells.
Kim SH; Cho YK; Huh JH; Kang JG; Ihm SH; Choi MG; Lee SJ
Anticancer Res; 2020 Nov; 40(11):6137-6150. PubMed ID: 33109551
[TBL] [Abstract] [Full Text] [Related]
9. Effect of mesoporous silica nanoparticles co‑loading with 17‑AAG and Torin2 on anaplastic thyroid carcinoma by targeting VEGFR2.
Wang C; Zhang R; Tan J; Meng Z; Zhang Y; Li N; Wang H; Chang J; Wang R
Oncol Rep; 2020 May; 43(5):1491-1502. PubMed ID: 32323855
[TBL] [Abstract] [Full Text] [Related]
10. Exosomes Play an Important Role in the Progression of Plasma Cell Mastitis via the PI3K-Akt-mTOR Signaling Pathway.
Wang X; Han Y; Liu J; Zhang Y; Cheng K; Guo J; Guo Q; Liu S; Sun H; Hua Y; Zhang G; Xu S; Guo F; Yang Z
Mediators Inflamm; 2019; 2019():4312016. PubMed ID: 31281227
[TBL] [Abstract] [Full Text] [Related]
11. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
[TBL] [Abstract] [Full Text] [Related]
12. [Mining and discovery for active components of "Coptidis Rhizome-Magnoliae Officinalis Cortex" based on network pharmacology].
Wu HN; Yu GH; Zhao FZ; Jia XB; Feng L; Shi XH
Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(4):803-810. PubMed ID: 30989895
[TBL] [Abstract] [Full Text] [Related]
13. Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic activities.
Ruhlmann M; Sonnenschein W; Nagarajah J; Binse I; Herrmann K; Jentzen W
Nucl Med Commun; 2018 May; 39(5):457-464. PubMed ID: 29517576
[TBL] [Abstract] [Full Text] [Related]
14. hsp90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract] [Full Text] [Related]
15. Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link.
Zahid H; Subbaramaiah K; Iyengar NM; Zhou XK; Chen IC; Bhardwaj P; Gucalp A; Morrow M; Hudis CA; Dannenberg AJ; Brown KA
Int J Obes (Lond); 2018 Apr; 42(4):711-720. PubMed ID: 29104286
[TBL] [Abstract] [Full Text] [Related]
16. Liposomal honokiol induced lysosomal degradation of hsp90 client proteins and protective autophagy in both gefitinib-sensitive and gefitinib-resistant NSCLC cells.
Yang J; Wu W; Wen J; Ye H; Luo H; Bai P; Tang M; Wang F; Zheng L; Yang S; Li W; Peng A; Yang L; Wan L; Chen L
Biomaterials; 2017 Oct; 141():188-198. PubMed ID: 28689115
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy of an hsp90 inhibitor, ganetespib, in preclinical thyroid cancer models.
Lin SF; Lin JD; Hsueh C; Chou TC; Yeh CN; Chen MH; Wong RJ
Oncotarget; 2017 Jun; 8(25):41294-41304. PubMed ID: 28476040
[TBL] [Abstract] [Full Text] [Related]
18. thyroid cancer incidence among Asian immigrants to Ontario, Canada: A population-based cohort study.
Shah BR; Griffiths R; Hall SF
Cancer; 2017 Sep; 123(17):3320-3325. PubMed ID: 28440952
[TBL] [Abstract] [Full Text] [Related]
19. hsp90 inhibitor NVP-AUY922 induces cell apoptosis by disruption of the survivin in papillary thyroid carcinoma cells.
Liu J; Sun W; Dong W; Wang Z; Qin Y; Zhang T; Zhang H
Biochem Biophys Res Commun; 2017 May; 487(2):313-319. PubMed ID: 28412368
[TBL] [Abstract] [Full Text] [Related]
20. Heat shock proteins hsp90, HSP70 and GRP78 expression in medullary thyroid carcinoma.
Soudry E; Stern Shavit S; Hardy B; Morgenstern S; Hadar T; Feinmesser R
Ann Diagn Pathol; 2017 Feb; 26():52-56. PubMed ID: 28038712
[TBL] [Abstract] [Full Text] [Related]
[Next]
